Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients
Open Access
- 13 June 2006
- journal article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 28 (1) , 33-41
Abstract
Aims At present, 20–30% of patients do not respond to cardiac resynchronization therapy (CRT). In this study, the relation between the extent of viable myocardium and scar tissue vs. response to CRT was evaluated. In addition, the presence of scar tissue in the left ventricular (LV) lead position was specifically related to response to CRT.Keywords
This publication has 23 references indexed in Scilit:
- Predictors of Lack of Response to Resynchronization TherapyThe American Journal of Cardiology, 2005
- Ventricular Reverse Remodeling and 6-Month Outcomes in Patients Receiving Cardiac Resynchronization Therapy: Analysis of the MIRACLE StudyJournal of Interventional Cardiac Electrophysiology, 2005
- Frequency of left ventricular dyssynchrony in patients with heart failure and a narrow QRS complexThe American Journal of Cardiology, 2005
- Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapyJACC, 2004
- Cardiogenic Shock Shortly After Initial Success of Cardiac Resynchronization TherapyEuropean Journal of Heart Failure, 2004
- Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 2004
- Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantationThe American Journal of Cardiology, 2003
- Effectiveness of resynchronization therapy in patients with end-stage heart failureThe American Journal of Cardiology, 2002
- Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failureThe American Journal of Cardiology, 2002
- Validity of the minnesota living with heart failure questionnaire as a measure of therapeutic response to enalapril or placeboThe American Journal of Cardiology, 1993